Status:

UNKNOWN

Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer.

Lead Sponsor:

IRCCS San Raffaele

Conditions:

Rectal Cancer

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

This study is designed as a prospective, multi-center, randomized, open-labelled, parallel group, non-inferiority trial. The aim of this study is to evaluate the TaTME technique compared with conventi...

Detailed Description

This study is designed as a prospective, multi-center, randomized, open-labelled, parallel group, non-inferiority trial. The patients will be randomized and assigned to transanal mesorectal excision (...

Eligibility Criteria

Inclusion

  • histologically proven solitary mid and low rectal cancer
  • proven by rigid rectoscopy, pelvic MRI and digital rectal examination (DRE)
  • amenable to curative sphincter-preserving surgery
  • no evidence of distant metastases (T3-4a,N0 or T1-4a,N1-2)
  • if evaluated after neoadiuvant therapy, no evidence of threaten of the mesorectal fascia (MRF) after therapy

Exclusion

  • no indication to perform sphincter preservation surgery (Tumors invading into the internal anal sphincter muscle based on pelvic MRI)
  • T4b tumor invading adjacent organs
  • recurrent cancer
  • concurrent or previous diagnosis of invasive cancer within 5 years
  • prior history of colorectal resection
  • tumors with in growth more than 1/3 of anal sphincter complex or levator ani.
  • presence of fecal incontinence at baseline according to Wexner's classification
  • emergent surgery with intestinal obstruction or perforation
  • absolute contraindications to general anaesthesia or prolonged pneumoperitoneum, such as severe cardiovascular or respiratory disease (ASA class \> III)

Key Trial Info

Start Date :

March 27 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 28 2023

Estimated Enrollment :

184 Patients enrolled

Trial Details

Trial ID

NCT03413904

Start Date

March 27 2018

End Date

February 28 2023

Last Update

August 9 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

IRCCS San Raffaele

Milan, Italy, 20060